It is the goal of this section to publish material that provides information regarding specific issues, aspects of artificial organ application, approach, philosophy, suggestions, and/or thoughts for the future. 5‐Lipoxygenase Gene Expression in Hemodialysis
- 1 February 1998
- journal article
- clinical trial
- Published by Wiley in Artificial Organs
- Vol. 22 (2) , 140-142
- https://doi.org/10.1046/j.1525-1594.1998.06047.x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- 5-lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes.The Journal of Experimental Medicine, 1993
- Regulation of 5-lipoxygenase and 5-lipoxygenase-activating protein expression in HL-60 cellsBiochemical Journal, 1993
- Generation of leukotriene B4 by hemodialyzer membranes: A novel index of biocompatibilityJournal of Molecular Medicine, 1991
- Leukotriene B4 in HemodialysisArtificial Organs, 1990
- Leukotriene B4 is involved in hemodialysis-associated neutropeniaBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
- Leukotrienes and Other Products of the 5-Lipoxygenase PathwayNew England Journal of Medicine, 1990
- Hemodialysis- Associated Induction of CytokinesBlood Purification, 1990
- Cytokines and BiocompatibilityBlood Purification, 1990
- Eicosanoid Release as Laboratory Indicator of BiocompatibilityArtificial Organs, 1989
- 4th Annual Meeting of the International Society of Blood PurificationBlood Purification, 1986